Novel TFAP2B mutations that cause Char syndrome provide a genotype-phenotype correlation
about
The AP-2 family of transcription factorsGAS41 interacts with transcription factor AP-2beta and stimulates AP-2beta-mediated transactivationEnvironmental estrogens alter early development in Xenopus laevis.The AP-2 Transcription Factor APTF-2 Is Required for Neuroblast and Epidermal Morphogenesis in Caenorhabditis elegans EmbryogenesisHuman CREB-binding protein/p300-interacting transactivator with ED-rich tail (CITED) 4, a new member of the CITED family, functions as a co-activator for transcription factor AP-2MATR3 disruption in human and mouse associated with bicuspid aortic valve, aortic coarctation and patent ductus arteriosusMyocardin regulates expression of contractile genes in smooth muscle cells and is required for closure of the ductus arteriosus in miceA heart-hand syndrome gene: Tfap2b plays a critical role in the development and remodeling of mouse ductus arteriosus and limb patterningMicroRNAs in the Myocyte Enhancer Factor 2 (MEF2)-regulated Gtl2-Dio3 Noncoding RNA Locus Promote Cardiomyocyte Proliferation by Targeting the Transcriptional Coactivator Cited2.Syndromic patent ductus arteriosus: evidence for haploinsufficient TFAP2B mutations and identification of a linked sleep disorder.Patterns of gene expression in the ductus arteriosus are related to environmental and genetic risk factors for persistent ductus patency.Transcription factor activating enhancer-binding protein-2beta. A negative regulator of adiponectin gene expression.Mutations of TFAP2B in congenital heart disease patients in Mysore, South India.Genomewide Association Study of African Children Identifies Association of SCHIP1 and PDE8A with Facial Size and Shape.Characterization of transcription factor AP-2 β mutations involved in familial isolated patent ductus arteriosus suggests haploinsufficiency.Effects of Advancing Gestation and Non-Caucasian Race on Ductus Arteriosus Gene Expression.Transcriptional analysis of human cranial compartments with different embryonic origins.Analysis of TFAP2A mutations in Branchio-Oculo-Facial Syndrome indicates functional complexity within the AP-2α DNA-binding domainTranscriptional regulation during development of the ductus arteriosus.Disorganized olfactory bulb lamination in mice deficient for transcription factor AP-2epsilonTranscription factor pathways and congenital heart disease.Genetic Modifiers of Patent Ductus Arteriosus in Term Infants.TFAP2B mutation and dental anomalies.Transcription factor AP-2beta inhibits expression and secretion of leptin, an insulin-sensitizing hormone, in 3T3-L1 adipocytes.Familial nonsyndromic patent ductus arteriosus caused by mutations in TFAP2B.Familial thoracic aortic aneurysm/dissection with patent ductus arteriosus: genetic arguments for a particular pathophysiological entity
P2860
Q21184171-946CCF55-4FE1-4374-9855-F8068D03890AQ24616799-8D61126D-CAC0-4845-97DE-CF9B165A965CQ24814216-B5FE54A0-C525-44E7-93F5-B0C983610460Q27308855-FA41542B-2837-46A3-8696-9F5687248154Q28211366-02478A7D-54F6-48D6-92C4-EE59ED380F43Q28506602-0C977CA6-C0A0-4DDF-9A19-9CC38AF70CD4Q28506846-2B8915A4-3068-4299-AB00-3DA3A21AC353Q28508787-1C633E73-F50C-4E4A-ADA4-374D4BCD4866Q33288820-D6EE8C89-65BE-45A5-AD21-236693EE9FFBQ33864543-EDCFE105-EBC2-432B-8317-C19E592A3701Q34134402-53898061-6014-49D3-B0D6-399C66F3AAA6Q34563647-63535A41-AD5E-45F6-8695-12ECC8A34992Q35646873-A48BEBBC-07A1-43CC-8090-739CF4B8B453Q36112972-CB7E59F8-983E-4906-8B44-E519DAC680B6Q36125674-309A09A5-D77D-4185-825F-C2EAC1ADA026Q36322633-4E6871EF-221F-4211-8A22-323EC2EE0780Q36572550-C0314F17-CDC7-4336-B4EF-95722C89A955Q37045093-8F322D25-92D2-4818-8BC8-60415F0BDFD6Q37103590-7EE65E80-AD8A-4B1F-9316-2D52BA1216E9Q37351397-67C6C1A1-E9C2-47E9-88D7-7A7369E9B65AQ37997218-BAF43AC4-874E-44B3-952A-2A59CFD1C659Q39655152-C3E29B55-1016-4B50-819E-8A3076ACDD45Q41192698-986AB3AD-89D7-405F-B4AB-9265843DA527Q42830507-5591BDB9-E1F2-4594-B7C4-A311ADB209E5Q45013401-8B21CD66-DF81-4903-A181-7E520BF2F03CQ55671012-C580864B-5D37-4A6E-9133-F07E831B81AA
P2860
Novel TFAP2B mutations that cause Char syndrome provide a genotype-phenotype correlation
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Novel TFAP2B mutations that cause Char syndrome provide a genotype-phenotype correlation
@ast
Novel TFAP2B mutations that cause Char syndrome provide a genotype-phenotype correlation
@en
Novel TFAP2B mutations that cause Char syndrome provide a genotype-phenotype correlation
@en-gb
Novel TFAP2B mutations that cause Char syndrome provide a genotype-phenotype correlation
@nl
type
label
Novel TFAP2B mutations that cause Char syndrome provide a genotype-phenotype correlation
@ast
Novel TFAP2B mutations that cause Char syndrome provide a genotype-phenotype correlation
@en
Novel TFAP2B mutations that cause Char syndrome provide a genotype-phenotype correlation
@en-gb
Novel TFAP2B mutations that cause Char syndrome provide a genotype-phenotype correlation
@nl
prefLabel
Novel TFAP2B mutations that cause Char syndrome provide a genotype-phenotype correlation
@ast
Novel TFAP2B mutations that cause Char syndrome provide a genotype-phenotype correlation
@en
Novel TFAP2B mutations that cause Char syndrome provide a genotype-phenotype correlation
@en-gb
Novel TFAP2B mutations that cause Char syndrome provide a genotype-phenotype correlation
@nl
P2093
P2860
P3181
P356
P1476
Novel TFAP2B mutations that cause Char syndrome provide a genotype-phenotype correlation
@en
P2093
C G Weismann
E M Thompson
M E Pierpont
P2860
P304
P3181
P356
10.1086/323410
P407
P577
2001-10-01T00:00:00Z